Synthetic Biologics
Executivos
Veja o organograma con seus 7 executivos principais
Biografias mais buscadas da Synthetic Biologics
- Steven Shallcross, Chief Executive Officer, Chief Financial Office...
- Jeffrey Kraws, Chairman of the Board
- Jeffrey Wolf, Director
Criar um alerta
para seguir os movimentos de executivos da Synthetic Biologics.
Biotecnologia
Synthetic Biologics possui 2.280 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Endeavor BioMedicines acaba de anunciar uma arrecadação de fundos de 132 milhões de dólares. (publicado em 25 de abril de 2024).
- Metsera acaba de anunciar uma arrecadação de fundos de 290 milhões de dólares. (publicado em 23 de abril de 2024).
- Histogen has filed for bankruptcy protection (publicado em 19 de abril de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Synthetic Biologics
- Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma | Theriva™ Biologics
- Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting | Theriva™ Biologics
- Theriva™ Biologics to Discuss the Trial Design for VIRAGE - a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma - at the 2024 American Society of Clinical Oncology (ASCO) Annua
- Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting | Theriva™ Biologics
- Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results | Theriva™ Biologics
- Theriva™ Biologics to Host Conference Call and Webcast to Discuss Full Year 2023 Operational Highlights and Financial Results | Theriva™ Biologics
- Theriva™ Biologics to Participate in the BIO-Europe Spring Conference | Theriva™ Biologics
- Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma | Theriva™ Biologics
- Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference | Theriva™ Biologics
- Theriva™ Biologics Reports Third Quarter 2023 Operational Highlights and Financial Results | Theriva™ Biologics
- View more press releases Close
Redes sociais sobre Synthetic Biologics
- Synthetic Biologics na Wikipedia, Google News e Yahoo Finance
- Synthetic Biologics na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo John Monahan 
Ligue para a Synthetic Biologics em +1 734...
